Lemon Stephenie C, Friedmann Peter D, Stein Michael D
Division of General Internal Medicine, Department of Medicine, Rhode Island Hospital, 593 Eddy Street, Providence, RI 02903, USA.
Addict Behav. 2003 Sep;28(7):1323-31. doi: 10.1016/s0306-4603(02)00259-9.
Although cigarette smoking is endemic among illicit drug users, drug abuse treatment programs rarely encourage smoking cessation and often discourage it. The purpose of this study was to determine whether smoking cessation after entering drug abuse treatment influenced drug use 12 months after drug abuse treatment. We analyzed 2316 cigarette smokers in the Drug Abuse Treatment Outcome Study (DATOS), a national, longitudinal study of drug abuse treatment. Heckman probit selection models assessed the association of self-reported smoking cessation while in drug abuse treatment on self-reported drug abstinence in the year after treatment completion, while simultaneously accounting for possible nonparticipation bias. Controlling for multiple factors, smoking cessation was associated with greater abstinence from drug use after completion of drug abuse treatment (P=.04). Despite drug abuse treatment programs' hesitance to encourage smokers to quit, smoking cessation does not negatively impact drug use outcomes.
尽管吸烟在非法药物使用者中很普遍，但药物滥用治疗项目很少鼓励戒烟，而且往往不支持戒烟。本研究的目的是确定进入药物滥用治疗后戒烟是否会影响药物滥用治疗12个月后的药物使用情况。我们分析了药物滥用治疗结果研究（DATOS）中的2316名吸烟者，这是一项关于药物滥用治疗的全国性纵向研究。赫克曼概率选择模型评估了在药物滥用治疗期间自我报告的戒烟与治疗完成后一年内自我报告的药物戒断之间的关联，同时考虑了可能的未参与偏差。在控制多个因素后，戒烟与药物滥用治疗完成后更高的药物戒断率相关（P = 0.04）。尽管药物滥用治疗项目对鼓励吸烟者戒烟有所犹豫，但戒烟并不会对药物使用结果产生负面影响。
